Phthalate Chemicals Tied to Costly Preterm Births in the United States
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 9, 2024 -- Hormone disruptor phthalate chemicals were associated with nearly 56,600 preterm births in the United States in 2018, according to a study published online Feb. 6 in The Lancet Planetary Health.
Leonardo Trasande, M.D., from the New York University Grossman School of Medicine in New York City, and colleagues examined associations between 20 phthalate metabolites and birth weight and gestational age. The analysis included data from 5,006 mother-child dyads participating in the U.S. National Institutes of Health Environmental Influences on Child Health Outcomes Program (1998 to 2022).
The researchers found that phthalic acid, diisodecyl phthalate (DiDP), di-n-octyl phthalate (DnOP), and diisononyl phthalate (DiNP) were most strongly associated with gestational age, birth length, and birth weight compared with di-2-ethylhexyl phthalate (DEHP) or other metabolite groupings. While DEHP was associated with preterm birth (odds ratio [OR], 1.45), the risks per log10 increase were higher for phthalic acid (OR, 2.71), DiNP (OR, 2.25), DiDP (OR, 1.69), and DnOP (OR, 2.90). An estimated 56,595 phthalate-attributable preterm birth cases occurred in 2018 with associated costs of US$3.84 billion.
"We identified associations of phthalate exposure with decreased gestational age in a large and diverse sample generally representative of the USA," the authors write. "This finding suggests the adverse consequences of substitution of DEHP with chemically similar phthalates and need to regulate chemicals with similar properties as a class."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity
THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.